Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-26Clinical Trial Update: A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]
This clinical trial update reports the results of a Phase 1 study of daratumumab in Japanese participants with relapsed or refractory multip…
-
CLINICAL_TRIALS trial_result · 2016-09-23Clinical Trial Update: Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial of cyclophosphamide, carfilzomib, thalidomide, and dexamethasone for newly diagnosed active multiple myeloma has completed w…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma [Phase 2]
Phase II trial update of an intensive TOTAL THERAPY regimen for untreated or minimally treated multiple myeloma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Clarithromycin in Multiple Myeloma Induction Therapy [Phase 2]
A Phase 2 clinical trial evaluating clarithromycin as part of induction therapy for multiple myeloma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan and fludarabine followed by post-transplant cyclophosphamide in patients with he…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]
A Phase 1 study evaluating lenalidomide (Revlimid) with all-trans retinoic acid (ATRA) and dexamethasone for relapsed/refractory multiple my…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients [Phase 2, Phase 3]
This clinical trial update notes the termination of a randomized Velcade-based regimen with autologous stem cell transplantation in newly di…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 clinical trial assessing the BRd regimen (bendamustine, lenalidomide, and dexamethasone) as second-line therapy for relapsed or refr…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer [Phase 2]
A Phase 2 efficacy study of ZD6474 (vandetanib) for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma [Phase 2]
Phase 2 clinical trial of bortezomib, dexamethasone, and doxorubicin with ALCAR in previously treated multiple myeloma completed; results po…
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Umbilical Cord Blood Transplant for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating umbilical cord blood transplantation for hematologic malignancies has completed enrollment and reporting.
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating continuous versus intermittent dosing of pomalidomide in relapsed/refractory multiple myeloma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma
This document reports the completed economic evaluation of using Plerixafor to support autologous hematopoietic stem cell transplantation in…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma [Phase 1, Phase 2]
An early-phase study of flavopiridol (alvocidib) in patients with relapsed or refractory lymphoma or multiple myeloma; the Phase 1/2 trial w…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) [Phase 3]
Phase 3 trial update for stem cell transplantation in individuals with multiple myeloma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus [Phase 2]
Phase 2 study evaluating unrelated cord blood transplantation using tacrolimus and sirolimus for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma [Phase 2]
Phase 2 study of TBL 12 sea cucumber extract in patients with untreated asymptomatic myeloma; the trial was terminated and results were post…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma [Phase 3]
A Phase 3 trial comparing ibandronate with zoledronic acid for nephrotoxicity in multiple myeloma was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: A Phase II Study of Umbilical Cord Blood Transplantation [Phase 2]
A Phase II study of Umbilical Cord Blood Transplantation was terminated, with results posted in 2016 for diseases including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders [Phase 2]
A Phase 2 trial testing nonmyeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors for multiple hematologic dis…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluating epoetin alfa for chemotherapy-induced anemia has completed, with an update summarizing trial status across multip…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Cancer Who Have Significant Weight Loss [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated omega-3 fatty acids for advanced cancer patients with significant weight loss; the study has comp…